메뉴 건너뛰기




Volumn 36, Issue 5, 2005, Pages 1063-1072

Development and validation for high selective quantitative determination of metformin in human plasma by cation exchanging with normal-phase LC/MS/MS

Author keywords

Cation exchange HPLC; Cation exchange solid phase extraction; Combination therapy; LC MS MS; Metformin; NIDDM; Normal phase

Indexed keywords

CYCLOSPORIN A; FLUINDOSTATIN; IMATINIB; METFORMIN; NATEGLINIDE; VALSARTAN;

EID: 11144277821     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2004.09.007     Document Type: Article
Times cited : (98)

References (30)
  • 27
    • 0003484310 scopus 로고    scopus 로고
    • US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Veterinary Medicine (CVM), May
    • Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Veterinary Medicine (CVM), May 2001. http://www.fda.gov/cder/guidance/index.htm.
    • (2001) Guidance for Industry: Bioanalytical Method Validation


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.